We are live on
!
Find out more
Outset Medical
Fund managers haven’t disclosed any holdings of OM yet.
OM Hedge Fund Activity: Q1 2026 in Review
99 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q1 2026, worth a combined $57.3M — down 1.3% from $58.1M a quarter earlier.
Fund positioning in OM was balanced in Q1 2026: 24 funds opened new positions, 24 closed out, 37 added to existing stakes and 23 trimmed.
The largest buyer was BML Capital Management, adding an estimated $5.57M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $5.99M sold.
- 99 institutional investors held Outset Medical (OM) as of Q1 2026, down from 100 in Q4 2025.
- Funds reported $57.3M of Outset Medical stock for Q1 2026, down 1.3% quarter-over-quarter.
- 24 funds opened new Outset Medical positions in Q1 2026 and 24 closed out, a net change of 0 holders.
- The largest Outset Medical buyer in Q1 2026 was BML Capital Management, an estimated $5.57M added.
- The largest Outset Medical seller in Q1 2026 was Alyeska Investment Group, an estimated $5.99M sold.
Based on aggregated 13F filings for Q1 2026.